Cargando…
A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors
The newly designed fentanyl derivative [( ±)-N-(3-fluoro-1-phenethylpiperidine-4-yl)-N-phenyl propionamide] (NFEPP) was recently shown to produce analgesia selectively via peripheral mu-opioid receptors (MOR) at acidic pH in rat inflamed tissues. Here, we examined the pH-dependency of NFEPP binding...
Autores principales: | Baamonde, Ana, Menéndez, Luis, González-Rodríguez, Sara, Lastra, Ana, Seitz, Viola, Stein, Christoph, Machelska, Halina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596718/ https://www.ncbi.nlm.nih.gov/pubmed/33122720 http://dx.doi.org/10.1038/s41598-020-75509-4 |
Ejemplares similares
-
Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018) -
LigpKa – a database of pKa values for small molecule ligands designed for the use in structure-based pKa calculations
por: Czodrowski, P, et al.
Publicado: (2011) -
pK(a) of opioid ligands as a discriminating factor for side effects
por: Del Vecchio, Giovanna, et al.
Publicado: (2019) -
Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal pain
por: Rodriguez-Gaztelumendi, Antonio, et al.
Publicado: (2018) -
Author Correction: pK(a) of opioid ligands as a discriminating factor for side effects
por: Del Vecchio, Giovanna, et al.
Publicado: (2020)